Senior Director, HEOR/RWE, Lung

Revolution Medicines; Redwood City (CA); On-site; USD 244,000 - 305,000; Full time

Job summary

Revolution Medicines in Redwood City, CA seeks a Senior Director, HEOR/RWE to lead strategy and execution of HEOR plans for NSCLC assets, demonstrating value to healthcare organizations and enabling informed decisions.

You will collaborate with Medical Affairs and cross-functional teams to optimize the Integrated Evidence Plan, generate global evidence, and guide access policies while advancing evidence-based medicine in oncology.

Qualifications

• Deep expertise in health economics, outcomes research, patient-reported outcomes or related fields in biopharma.
• Experience in oncology HEOR and RWE development.
• Track record of high-impact publications in HEOR/RWE topics.
• Strong written and interpersonal communication skills, with ability to present complex technical information clearly.
• Knowledge of managed care, formulary decision-making, and payment/access models.
• Ability to engage with RWE experts and therapeutic areas.

Responsibilities

• Align with Medical Affairs and Development leadership to design research and deliver evidence aligned with the medical strategy and IEP.
• Develop and evolve product HEOR/RWE strategy globally, integrating with development, commercial, regulatory, and market access planning.
• Deliver HEOR/RWE tactics with quality and on schedule.
• Provide HEOR/RWE leadership on matrix teams and working groups.
• Communicate value insights to internal teams of key stakeholders.
• Provide HEOR evidence addressing needs of patients, providers, payers and HTA agencies.
• Lead enterprise partnerships with payers, HTA agencies, and global consortia to shape access strategy and evidence generation.
• Present research findings to internal and external stakeholders to support decision making and adoption.
• Articulate the value proposition of Revolution Medicines' portfolio to inform therapeutic decisions.
• Engage external partners to gather insights and co-create value evidence.
• Coordinate real-world research engagements with healthcare, academic and payer organizations.
• Stay up to date with health economics methodologies and best practices.
• Identify HEOR & RWE experts and data sources related to portfolio.
• Monitor payer environment trends and communicate gaps to build leading capabilities.

Skills

HEOR & RWE

Oncology HEOR

Publications in HEOR

Communication skills

Managed care knowledge

RWE methods

Job description

About Revolution Medicines

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi‑selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C‑selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D‑selective inhibitor; and RMC‑5127, a RAS(ON) G12V‑selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

Opportunity

The Senior Director, HEOR/RWE is responsible for developing the strategy and executing HEOR plans and activities related to all Revolution Medicines assets intended for use in non‑small cell lung cancer (NSCLC). They will be accountable for demonstrating the value of Revolution Medicines products to healthcare organizations, allowing them to make informed decisions. They will work closely with the Medical Affairs team as well as other cross‑functional teams to optimize the Integrated Evidence Plan (IEP) and to deliver evidence supporting the use of Revolution Medicines products. The candidate must also be able to provide input and strategic guidance on the global value of the product as well as have demonstrated success in evidence generation globally. The Senior Director HEOR/RWE will participate with the matrix team across the function to ensure alignment of all activities with the strategic and tactical plans. This is an exceptional opportunity to contribute to the advancement of healthcare by providing evidence that can shape the future of patient care in oncology.

Responsibilities

• Align with Medical Affairs and Development leadership to design research and deliver evidence consistent with the medical strategy and IEP.
• Develop and evolve product HEOR/RWE strategy globally, including integration with development, commercial, regulatory, and market access planning.
• Deliver HEOR/RWE tactics with quality and in alignment with agreed upon timing.
• Provide HEOR/RWE leadership on matrix teams and working groups.
• Work with the HEOR/RWE and Medical Affairs leadership to ensure critical value insights are communicated to key internal teams.
• Provide HEOR evidence which addresses the needs and expectations of key stakeholders such as patients, healthcare providers, payers and Health Technology Assessment (HTA) agencies.
• Lead enterprise partnerships with payers, HTA agencies, and global consortia to help shape access strategy, policies, evidence standards, and evidence generation activities.
• Effectively present research findings to internal and external stakeholders to improve internal decision making and to promote wider adoption of research findings across external stakeholders.
• Facilitate the communication of the value proposition of Revolution Medicines’ portfolio, allowing key healthcare and formulary professionals to make informed therapeutic decisions.
• Engage and collaborate with external partners including payers, health care providers, thought leaders, patient advocates, and decision‑makers to establish and maintain strong partnerships and gather insights into research programs.
• Facilitate and implement real‑world research partnership engagements with leading healthcare, academic and payer organizations to co‑create value evidence and help drive evidence‑based optimal care.
• Stay up to date with and add to the advancements in health economics methodologies and best practices.
• Identify and interface with HEOR & RWE experts and organizations, profile data sources and related organizations as they relate to Revolution Medicines’ portfolio and therapeutic areas.
• Closely monitor new trends in health policy and payer environment, assess competitive data gaps and communicate to the organization, to help Revolution Medicines build industry‑leading capabilities and be on the cutting edge of evidence‑based medicine and HEOR research.

Required Skills, Experience and Education

• Deep expertise in health economics, outcomes research, patient‑reported outcomes or related fields in the biotechnology or pharmaceutical industry.
• Experience in oncology HEOR and RWE development.
• Track record of high‑impact publications in HEOR/RWE topics.
• Strong written and interpersonal communication skills, with an ability to present complex technical information clearly.
• Knowledge and experience in managed care, integrated delivery networks, formulary decision‑making, and payment/access models.
• Ability to establish relationships with experts in real‑world evidence (RWE) and therapeutic areas of interest.

Preferred Skills

• 12+ years of relevant experience in the pharmaceutical/biotech industry.
• Global launch experience.
• Experience related to NSCLC.

Compensation

Base Pay Salary Range: $244,000–$305,000 USD (at our Redwood City, CA headquarters; adjusted for local market).

Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by phone or email. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [e-mail].